Opportunity

Federal Register #Docket No. 9437

FTC Consent Order on Insulin Pricing and CDC Influenza Surveillance Funding

Buyer

Federal Trade Commission

Posted

August 05, 2026

Respond By

September 04, 2026

Identifier

Docket No. 9437

This notice details actions by the Federal Trade Commission (FTC) and the Centers for Disease Control and Prevention (CDC) regarding healthcare market practices and public health funding. - Government Buyers: - Federal Trade Commission (FTC) - Centers for Disease Control and Prevention (CDC) - OEMs and Vendors Mentioned: - Caremark Rx, L.L.C. - Zinc Health Services, LLC - Universidad Peruana Cayetano Heredia (as a funding recipient) - Nine African public health institutes (as funding recipients) - Products/Programs/Services Requested or Announced: - Copay Certainty Program for Insulin (caps out-of-pocket insulin costs for members) - Funding for influenza surveillance and response support in Peru and Africa - Key Requirements and Notable Provisions: - FTC proposes a 10-year consent order requiring Caremark to: - Place low wholesale acquisition cost (WAC) drugs on formularies - Cap insulin copays at $25 (0-34 days), $50 (35-68 days), $75 (69+ days) - Increase transparency in pharmacy benefit management - Improve pharmacy reimbursement practices - CDC awards support: - Enhanced capacity for seasonal influenza surveillance - Pandemic and novel influenza detection and response - Infectious disease outbreak identification - No specific product purchases or quantities are being solicited; this is not a procurement or contract award notice.

Description

This notice from the Federal Trade Commission announces a proposed consent agreement related to alleged violations of federal law prohibiting unfair methods of competition by Caremark. The agreement aims to protect the public from anticompetitive conduct by Caremark and includes provisions to reduce out-of-pocket costs for members, ensure benefits of rebates at the point of sale, and create a Copay Certainty Program for insulin. Comments on the proposed agreement are requested and must be submitted by September 4, 2026. The full text and related documents are available online.

View original listing